CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 4 Grant or award Director acquired 647 shares (grant or award)
- 4 Open-market sale Director sold 8,600 shares at $6.32 ($54,352)
- 4 Open-market sale Director sold 4,689 shares at $6.00 ($28,134)
- 4 Grant or award Director acquired 6,820 shares (grant or award)
- 4 Grant or award Director acquired 6,820 shares (grant or award)
- 4 Grant or award Director acquired 6,820 shares (grant or award)
- 4 Grant or award Director acquired 6,820 shares (grant or award)
- 4 Grant or award Director acquired 6,820 shares (grant or award)
- 4 Open-market sale Director sold 6,698 shares at $6.11 ($40,925)
- 4 Grant or award Director acquired 6,820 shares (grant or award)
- 4 Grant or award Director acquired 6,820 shares (grant or award)
- 4 Grant or award Director acquired 6,820 shares (grant or award)
- 4 Grant or award Director acquired 870 shares (grant or award)
- 4 Grant or award Director acquired 870 shares (grant or award)
- 4 Open-market buy Director bought 7,861 shares at $6.36 ($49,996)
- 4 Open-market buy Director bought 2,500 shares at $6.40 ($16,000)
- 4 Open-market buy Director bought 5,000 shares at $6.38 ($31,900)
- 4 Open-market buy Director bought 15,000 shares at $6.25 ($93,750)
- 4 Open-market buy Chief Financial Officer bought 36,300 shares at $5.57 ($202,191)
- 4 Open-market buy Chief R&D Officer bought 30,000 shares at $5.86 ($175,800)
Page 5 of 49 · 965 filings